James Allison

James Allison is a renowned immunologist whose research has advanced our understanding of how the body's immune system can be harnessed to fight cancer. He discovered a way to block a molecule called CTLA-4, which normally acts as a brake on immune cells, allowing the immune system to better recognize and attack tumors. His work laid the foundation for immune checkpoint therapy, a groundbreaking cancer treatment that has significantly improved outcomes for many patients. In 2018, Allison was awarded the Nobel Prize in Physiology or Medicine for his contributions to cancer immunotherapy.